Table 5.
Comparison of Investigators’ and Patients’ Satisfaction Evaluation Among the Treatment Groups
| Evaluation | Treatment (Group) | p-value between groups a | ||||||
|---|---|---|---|---|---|---|---|---|
| A | B | C | ||||||
| n | % | n | % | n | % | |||
| Investigators’ Satisfaction Score | ||||||||
| D28 | 1 | 1 | 1.00% | 0 | 0.00% | 0 | 0.00% | <0.001* |
| 2 | 21 | 21.90% | 1 | 1.10% | 1 | 1.10% | ||
| 3 | 47 | 49.00% | 18 | 18.90% | 17 | 18.10% | ||
| 4 | 27 | 28.10% | 71 | 74.70% | 71 | 75.50% | ||
| 5 | 0 | 0.00% | 5 | 5.30% | 5 | 5.30% | ||
| D56 | 1 | 1 | 1.00% | 1 | 1.10% | 0 | 0.00% | <0.001* |
| 2 | 17 | 17.70% | 1 | 1.10% | 3 | 3.20% | ||
| 3 | 39 | 40.60% | 13 | 13.80% | 14 | 14.90% | ||
| 4 | 39 | 40.60% | 72 | 76.60% | 64 | 68.10% | ||
| 5 | 0 | 0.00% | 7 | 7.40% | 13 | 13.80% | ||
| p-value D28 - D56 within groupb | 0.021 | 0.503 | 0.276 | |||||
| Patients’ Satisfaction score | ||||||||
| D28 | 0 | 96 | 100.00% | 0 | 0.00% | 0 | 0.00% | 0.100c |
| 2 | 0 | 0.00% | 2 | 2.10% | 1 | 1.10% | ||
| 3 | 0 | 0.00% | 27 | 28.40% | 19 | 20.20% | ||
| 4 | 0 | 0.00% | 57 | 60.00% | 71 | 75.50% | ||
| 5 | 0 | 0.00% | 9 | 9.50% | 3 | 3.20% | ||
| D56 | 0 | 96 | 100.00% | 0 | 0.00% | 0 | 0.00% | 0.267c |
| 1 | 0 | 0.00% | 1 | 1.10% | 0 | 0.00% | ||
| 2 | 0 | 0.00% | 2 | 2.10% | 3 | 3.20% | ||
| 3 | 0 | 0.00% | 10 | 10.60% | 20 | 21.30% | ||
| 4 | 0 | 0.00% | 68 | 72.30% | 60 | 63.80% | ||
| 5 | 0 | 0.00% | 13 | 13.80% | 11 | 11.70% | ||
| p-value D28 - D56 within groupb | 1 | 0.005 | 0.623 | |||||
Notes: *statistically significant with p<0.005; aChi square test, 1–2 and 3–4 levels were combined; bMcNemar test; ccomparison between B and C Groups only, 1–2 and 3–4 levels were combined.